Catalent Pharma Solutions filed 78 H-1B LCAs in FY2025. Average salary: $104k.
Catalent Pharma Solutions sponsored 78 H-1B positions during the FY FY2025 cycle, offering an average of $104k. Top positions include Technician, Biomanufacturing, Downstream/mRNA (17%), Manufacturing Technical Operations Specialist (14%), Sr. Specialist, Quality Assurance Batch Disposition (6%). Filings were concentrated in Maryland (42%), Wisconsin (31%), Kentucky (6%). The certification rate was 99%. Salaries ranged from $53k to $450k.
| Percentile | Salary |
|---|---|
| 10th | $54k |
| 25th | $68k |
| 50th (Median) | $100k |
| 75th | $123k |
| 90th | $150k |
Based on 78 salary records. Range: $53k – $450k.
92% of filings offer salaries above the prevailing wage, with an average premium of 16.9%. The average prevailing wage is $89k (based on 78 filings).
Average processing time is 8 days (median: 7 days). Fastest: 4 days, slowest: 41 days. Based on 78 filings.
49% of filings are for new positions, while 13% are for continued employment (78 filings).
Average contract duration: 35 months (median: 36 months), based on 78 filings.
| Education Level | Filings |
|---|---|
| Not Specified | 78 |
| Job Title | Filings |
|---|---|
| Technician, Biomanufacturing, Downstream/mRNA | 13 |
| Manufacturing Technical Operations Specialist | 11 |
| Sr. Specialist, Quality Assurance Batch Disposition | 5 |
| Technician, Biomanufacturing, Upstream | 3 |
| Computer Systems Validation Engineer | 2 |
| Batch Record Reviewer | 2 |
| Enterprise Data Scientist | 2 |
| Development Scientist | 2 |
| Manager, Computer System Validation | 1 |
| Sr. Quality Systems Specialist | 1 |
Catalent Pharma Solutions filed 78 H-1B Labor Condition Applications (LCAs) in FY2025.
The average H-1B salary at Catalent Pharma Solutions in FY2025 was $104k.
The top H-1B job titles sponsored by Catalent Pharma Solutions in FY2025 include Technician, Biomanufacturing, Downstream/mRNA, Manufacturing Technical Operations Specialist, Sr. Specialist, Quality Assurance Batch Disposition.